6309 Monarch Park Place, Suite 203
Niwot, CO 80503, USA
Phone (303) 443-5060
Toll free (888) 742-5060
Thermo Fisher Scientific Inc. (NYSE: TMO), Waltham, MA, has agreed to acquire Brammer Bio for $1.7 billion. The acquisition would expand the lab-equipment company’s presence in the field of gene therapy.
Brammer Bio, owned by private-equity firm Ampersand Capital Partners, provides pharmaceutical companies developing gene therapies and gene-modified cell therapies with outsourced research and drug making services.
Brammer Bio was formed in 2016 through the merger of Brammer Biopharmaceuticals and Florida Biologix.